Table 1 Demographic characteristics of 295 patients who underwent total hip arthroplasty
From: Tranexamic versus aminocaproic acids in patients with total hip arthroplasty: a retrospective study
Demographics | Control (n = 104) | EACA (n = 97) | TXA (n = 94) |
|---|---|---|---|
Mean (and SD) age, yr | 61.80 (9.641) | 63.31 (8.237) | 63.89 (8.430) |
Gender, male: female | 49: 55 | 36: 61 | 29: 65 |
Diagnosis, no. (and %) of patients | |||
Toxic osteonecrosis | 29 (27.9) | 25 (25.8) | 30 (31.9) |
Dysplastic hips | 35 (33.7) | 24 (24.7) | 22 (23.4) |
Femoral neck fractures | 22 (21.2) | 29 (29.9) | 31 (33.0) |
Hip osteoarthritis | 14 (13.5) | 18 (18.6) | 9 (9.6) |
Other hip diseases | 4 (3.8) | 1 (1.0) | 2 (2.1) |
Mean (and SD) body mass index, kg/m2 | 24.73 (3.263) | 24.19 (3.088) | 23.83 (3.628) |
Mean (and SD) operation time, min | 89.45 (39.975) | 74.80 (29.795)* | 70.00 (17.629)† |
Mean (and SD) hospitalization time, day | 12.02 (3.478) | 11.51 (4.435) | 11.23 (3.697) |
Mean (and SD) postoperative hospitalization time, day | 8.19 (1.199) | 7.96 (1.190) | 8.00 (1.117) |